These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 2367614

  • 1. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.
    Lopez AL, Kathol RG, Noyes R.
    Psychoneuroendocrinology; 1990; 15(1):23-8. PubMed ID: 2367614
    [Abstract] [Full Text] [Related]

  • 2. Agoraphobia and panic disorder: treatment with alprazolam.
    Mark SL.
    Tex Med; 1984 Oct; 80(10):50-2. PubMed ID: 6150561
    [No Abstract] [Full Text] [Related]

  • 3. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP, Pecknold JC, Kuch K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Oct; 11(2-3):105-13. PubMed ID: 3628823
    [Abstract] [Full Text] [Related]

  • 4. Taper withdrawal studies with alprazolam in patients with panic disorder and agoraphobia.
    Pecknold JC, Swinson RP.
    Psychopharmacol Bull; 1986 Oct; 22(1):173-6. PubMed ID: 3726063
    [No Abstract] [Full Text] [Related]

  • 5. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R, Kahn RJ, McNair DM, Frankenthaler LM.
    Psychopharmacol Bull; 1986 Oct; 22(1):167-72. PubMed ID: 2873609
    [No Abstract] [Full Text] [Related]

  • 6. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 7. Some biochemical correlates of panic attacks with agoraphobia and their response to a new treatment.
    Sheehan DV, Coleman JH, Greenblatt DJ, Jones KJ, Levine PH, Orsulak PJ, Peterson M, Schildkraut JJ, Uzogara E, Watkins D.
    J Clin Psychopharmacol; 1984 Apr; 4(2):66-75. PubMed ID: 6142907
    [Abstract] [Full Text] [Related]

  • 8. Benzodiazepines in panic disorder and agoraphobia.
    Sheehan DV.
    J Affect Disord; 1987 Apr; 13(2):169-81. PubMed ID: 2890678
    [Abstract] [Full Text] [Related]

  • 9. Diazepam and propranolol in panic disorder and agoraphobia.
    Noyes R, Anderson DJ, Clancy J, Crowe RR, Slymen DJ, Ghoneim MM, Hinrichs JV.
    Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
    [Abstract] [Full Text] [Related]

  • 10. HPA axis disturbance and treatment outcome in panic disorder.
    Coryell W, Noyes R.
    Biol Psychiatry; 1988 Nov; 24(7):762-6. PubMed ID: 3067754
    [Abstract] [Full Text] [Related]

  • 11. Direct comparison of urinary free cortisol excretion in patients with depression and panic disorder.
    Kathol RG, Anton R, Noyes R, Gehris T.
    Biol Psychiatry; 1989 Apr 01; 25(7):873-8. PubMed ID: 2720002
    [Abstract] [Full Text] [Related]

  • 12. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
    Munjack DJ, Crocker B, Cabe D, Brown R, Usigli R, Zulueta A, McManus M, McDowell D, Palmer R, Leonard M.
    J Clin Psychopharmacol; 1989 Feb 01; 9(1):22-7. PubMed ID: 2651490
    [Abstract] [Full Text] [Related]

  • 13. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM, Rubin RT, Rifkin A, Swinson RP, Ballenger JC, Burrows GD, Dupont RL, Noyes R, Pecknold JC.
    J Affect Disord; 1989 Feb 01; 16(1):49-58. PubMed ID: 2521651
    [Abstract] [Full Text] [Related]

  • 14. Reduction in hypochondriasis with treatment of panic disorder.
    Noyes R, Reich J, Clancy J, O'Gorman TW.
    Br J Psychiatry; 1986 Nov 01; 149():631-5. PubMed ID: 3814956
    [Abstract] [Full Text] [Related]

  • 15. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD.
    Arch Gen Psychiatry; 1988 May 01; 45(5):423-8. PubMed ID: 3358644
    [Abstract] [Full Text] [Related]

  • 16. Relationship of urinary free cortisol levels in patients with panic disorder to symptoms of depression and agoraphobia.
    Kathol RG, Noyes R, Lopez AL, Reich JH.
    Psychiatry Res; 1988 May 01; 24(2):211-21. PubMed ID: 3406239
    [Abstract] [Full Text] [Related]

  • 17. Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.
    Gastfriend DR, Rosenbaum JF.
    Am J Psychiatry; 1989 Jul 01; 146(7):914-6. PubMed ID: 2568095
    [Abstract] [Full Text] [Related]

  • 18. Clonazepam in the treatment of panic disorder and agoraphobia.
    Pollack MH, Rosenbaum JF, Tesar GE, Herman JB, Sachs GS.
    Psychopharmacol Bull; 1987 Jul 01; 23(1):141-4. PubMed ID: 3110854
    [No Abstract] [Full Text] [Related]

  • 19. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May 01; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 20. Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks.
    Coryell W, Noyes R, Clancy J, Crowe R, Chaudhry D.
    Psychiatry Res; 1985 Aug 01; 15(4):301-11. PubMed ID: 2866558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.